• DSRU’s 9th Signal Detection Conference is a great success!

    Our biennial Signal Detection Conferences have built up a loyal following in the pharmacovigilance community since the first conference in 2001. It was a pleasure to see many familiar faces at last week’s 9th Signal Detection Conference, as well as to welcome many newcomers. The majority of delegates attended the pre-conference tutorial day, which had been redesigned […]

    >Continue reading
  • BMJ feature on DSRU’s Brexit Forum

    Nigel Hawkes’ feature in the BMJ (http://www.bmj.com/content/357/bmj.j2168 published 17th May 2017) outlines some of the concerns raised at the DSRU’s Forum on UK Pharmacovigilance post-Brexit, which was held in London on 26th April. He notes that while the European Medicines Agency (EMA) would have to be relocated in order to remain within the EU, UK […]

    >Continue reading
  • Blog: Measuring the Impact of Pharmacovigilance 

    Saad Shakir writes: Huge efforts and resources have been allocated to Pharmacovigilance around the world, with enormous progress in the last two decades. Signal Detection, Risk Management and Risk Minimisation are only a few examples of fairly recent developments.  The effects of these and other developments in Pharmacovigilance are real and there are metrics that measure […]

    >Continue reading
  • What are the main objectives of PASS studies for Risk Management?

    In this short blog and video, Saad Shakir outlines the main objectives for PASS studies and describes the characteristics of those who are able to conduct such studies: The objectives of Risk Management Studies are essentially to reduce the uncertainties related to the limitations of pre-marketing data and examine the effects of the different characteristics […]

    >Continue reading